U.S. flag

An official website of the United States government

NM_130837.3(OPA1):c.205C>G (p.Pro69Ala) AND not specified

Germline classification:
Likely benign (1 submission)
Last evaluated:
May 20, 2013
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000200222.1

Allele description [Variation Report for NM_130837.3(OPA1):c.205C>G (p.Pro69Ala)]

NM_130837.3(OPA1):c.205C>G (p.Pro69Ala)

Gene:
OPA1:OPA1 mitochondrial dynamin like GTPase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q29
Genomic location:
Preferred name:
NM_130837.3(OPA1):c.205C>G (p.Pro69Ala)
Other names:
p.Pro69Ala
HGVS:
  • NC_000003.12:g.193614895C>G
  • NG_011605.1:g.26752C>G
  • NM_001354663.2:c.-168C>G
  • NM_001354664.2:c.-168C>G
  • NM_015560.3:c.205C>G
  • NM_130831.3:c.205C>G
  • NM_130832.3:c.205C>G
  • NM_130833.3:c.205C>G
  • NM_130834.3:c.205C>G
  • NM_130835.3:c.205C>G
  • NM_130836.3:c.205C>G
  • NM_130837.3:c.205C>GMANE SELECT
  • NP_056375.2:p.Pro69Ala
  • NP_056375.2:p.Pro69Ala
  • NP_570844.1:p.Pro69Ala
  • NP_570845.1:p.Pro69Ala
  • NP_570846.1:p.Pro69Ala
  • NP_570847.2:p.Pro69Ala
  • NP_570848.1:p.Pro69Ala
  • NP_570849.2:p.Pro69Ala
  • NP_570850.2:p.Pro69Ala
  • LRG_337t1:c.205C>G
  • LRG_337:g.26752C>G
  • LRG_337p1:p.Pro69Ala
  • NC_000003.11:g.193332684C>G
  • NM_015560.2:c.205C>G
  • p.P69A
Protein change:
P69A
Links:
dbSNP: rs750775588
NCBI 1000 Genomes Browser:
rs750775588
Molecular consequence:
  • NM_001354663.2:c.-168C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354664.2:c.-168C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_015560.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130831.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130832.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130833.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130834.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130835.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130836.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130837.3:c.205C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000251976GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely benign
(May 20, 2013)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000251976.11

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024